<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="8507" OLDID="14028" TOPICS="NO">
<DATE>23-MAR-1987 16:17:44.27</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f2359 reute
r f BC-ADVANCED-VIRAL-RESEAR   03-23 0069</UNKNOWN>
<TEXT> 
<TITLE>ADVANCED VIRAL RESEARCH PLANT SET FOR APPROVAL</TITLE>
<DATELINE>    MIAMI BEACH, Fla., March 23 - </DATELINE><BODY>&lt;Advanced Viral Research 
Corp&gt; said its facility to manufacture reticulose, an anti-
viral agent, is ready for FDA inspection.
    The company said it will make a formal request for the
review by the end of March.
    The company said if the facility is approved, initial tests
and trials on AIDS patients will start soon afterward.
 Reuter
 </BODY></TEXT>
</REUTERS>